newsfilter
← Latest News
GlobeNewswire·

Immatics Appoints Alise Reicin to Board of Directors

Houston, Texas and Tuebingen, Germany, July 31, 2024 – Immatics N.V. (NASDAQ:IMTX, "Immatics" or the "Company")), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting